Back to top

AXSM Maintains Buy Rating by TD Cowen -- Price Target Raised to $300

AXSM Maintains Buy Rating by TD Cowen -- Price Target Raised to $300

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Axsome Therapeutics, Inc. (AXSM)